Vivpro Corp

Only two days remain to take advantage of early bird registration for RECON 2025! 𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐭𝐨𝐝𝐚𝐲!🎉 ➡ https://lnkd.in/gE6WZtuj Why attend? 1. Discover cutting-edge internal and external R&D intelligence techniques driving successful drug development. 2. Learn from real-world examples of transformative industry breakthroughs. 3. Connect with like-minded professionals, expand your network, and engage in meaningful discussions. 🔎 Explore the Agenda: https://lnkd.in/girYwv7j Our speaker lineup includes luminaries from the FDA, industry leaders, and academia. Over the course of the two-day conference, we will delve into: 1. 𝐁𝐢𝐨𝐦𝐚𝐫𝐤𝐞𝐫 𝐭𝐨 𝐄𝐧𝐝𝐩𝐨𝐢𝐧𝐭 𝐓𝐫𝐚𝐧𝐬𝐥𝐚𝐭𝐢𝐨𝐧 - Establishing surrogate endpoints. 2. 𝐆𝐥𝐨𝐛𝐚𝐥 𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐇𝐚𝐫𝐦𝐨𝐧𝐢𝐳𝐚𝐭𝐢𝐨𝐧 - Towards a streamlined global regulatory assessment. 3. 𝐏𝐫𝐨𝐣𝐞𝐜𝐭 𝐎𝐩𝐭𝐢𝐦𝐮𝐬 - R&D strategies, practicality, and collaboration between FDA and sponsors. 4. 𝐃𝐢𝐯𝐞𝐫𝐬𝐢𝐭𝐲 𝐢𝐧 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐓𝐫𝐢𝐚𝐥𝐬 - Strategies and implications for enhancing clinical trial diversity. Spread the word among your colleagues- we can't wait to welcome you all there! #RECON #UniversityOfMarylandBaltimore #DrugDevelopment #Pharma #BioTech #FDA #ProjectOptimus #ClinicalTrials #RegulatoryStrategy #Biomarkers #Endpoints #RegulatoryHarmonization #VivproCorp #MorePowerToYou

𝐃𝐨𝐧’𝐭 𝐦𝐢𝐬𝐬 𝐨𝐮𝐭 𝐨𝐧 𝐭𝐡𝐞 𝐞𝐚𝐫𝐥𝐲 𝐛𝐢𝐫𝐝 𝐩𝐫𝐢𝐜𝐢𝐧𝐠 𝐟𝐨𝐫 𝐑𝐄𝐂𝐎𝐍 2025! 𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐭𝐨𝐝𝐚𝐲! ➡ https://lnkd.in/gE6WZtuj Join us at the University of Maryland, Baltimore, on January 27 & 28, 2025. Meet Kevin Carl, Global Head of Regulatory Affairs and Development at Novartis, and Shivani Shah, Senior Global Program Regulatory Manager at Novartis. Together, they co-chair the 𝐆𝐥𝐨𝐛𝐚𝐥 𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐇𝐚𝐫𝐦𝐨𝐧𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐓𝐫𝐚𝐜𝐤. They are spearheading important conversations in today's ever-evolving regulatory landscape. Don't miss this opportunity to engage in intimate discussions with the experts. We can't wait to see you there! #RECON #UniversityOfMarylandBaltimore #DrugDevelopment #RegulatoryHarmonization #ProjectOptimus #Pharma #ClinicalTrials #DoseOptimization #ClinicalTrialDiversity #Biomarkers #RegulatoryStrategy #FDA #RegulatoryHarmonization #VivproCorp #MorePowerToYou

Hurry up and grab the early bird pricing for RECON 2025 before it's gone! 𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐭𝐨𝐝𝐚𝐲! ➡ https://lnkd.in/g84STPHx Join us at the University of Maryland, Baltimore, on January 27 & 28, 2025. Meet Peter Morcos, Senior Director of Clinical Pharmacology at Bayer. On Day 2, he will lead us on the 𝐏𝐫𝐨𝐣𝐞𝐜𝐭 𝐎𝐩𝐭𝐢𝐦𝐮𝐬 𝐓𝐫𝐚𝐜𝐤, riding the wave of continuous innovation and breakthroughs. Join us for an insightful discussion with experts from the federal agency and industry as they dive into case studies of dose optimization. Don't miss this opportunity to engage in intimate discussions with the experts. We can't wait to see you there! #RECON #UniversityOfMarylandBaltimore #DrugDevelopment #ProjectOptimus #Pharma #ClinicalTrials #DoseOptimization #ClinicalTrialDiversity #Biomarkers #RegulatoryStrategy #FDA #RegulatoryHarmonization #VivproCorp #MorePowerToYou

🎉 We are incredibly proud to announce that our co-founder, Professor Joga Gobburu, will be delivering the keynote address at the #AAPS conference! His talk will focus on how cutting-edge AI scientific analytics are driving the discovery and development of breakthrough medicines. At Vivpro Corp, we are at the forefront of this transformation, harnessing AI to accelerate drug development to improve patient's lives. #AI #DrugDevelopment #Pharma #Innovation #BreakthroughMedicine #Leadership #VivproCorp

Hurry up and take advantage of the early bird pricing for 𝐑𝐄𝐂𝐎𝐍 2025! Join us at the University of Maryland, Baltimore, on January 27 & 28, 2025. 𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐭𝐨𝐝𝐚𝐲!🎉 ➡ https://lnkd.in/g84STPHx Get ready to navigate the fast-changing regulatory landscape and explore key industry topics. Our goal is to prepare, motivate, and advance you and your organization for growth. Join us for four tracks and engaging panel discussions with industry experts. Over the course of the two-day conference, we will delve into: 1. 𝐁𝐢𝐨𝐦𝐚𝐫𝐤𝐞𝐫 𝐭𝐨 𝐄𝐧𝐝𝐩𝐨𝐢𝐧𝐭 𝐓𝐫𝐚𝐧𝐬𝐥𝐚𝐭𝐢𝐨𝐧 - Establishing reasonable surrogate endpoints. 2. 𝐆𝐥𝐨𝐛𝐚𝐥 𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐇𝐚𝐫𝐦𝐨𝐧𝐢𝐳𝐚𝐭𝐢𝐨𝐧 - Towards a streamlined global regulatory assessment. 3. 𝐏𝐫𝐨𝐣𝐞𝐜𝐭 𝐎𝐩𝐭𝐢𝐦𝐮𝐬 - R&D strategies, practicality, and collaboration between FDA and sponsors. 4. 𝐃𝐢𝐯𝐞𝐫𝐬𝐢𝐭𝐲 𝐢𝐧 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐓𝐫𝐢𝐚𝐥𝐬 - Strategies and implications for enhancing clinical trial diversity. Spread the word among your colleagues- we can't wait to welcome you all there! #RECON #UniversityOfMarylandBaltimore #DrugDevelopment #Pharma #BioTech #FDA #ProjectOptimus #ClinicalTrials #RegulatoryStrategy #Biomarkers #Endpoints #RegulatoryHarmonization #VivproCorp #MorePowerToYou

Register now for RECON 2025! 𝐓𝐚𝐤𝐞 𝐚𝐝𝐯𝐚𝐧𝐭𝐚𝐠𝐞 𝐨𝐟 𝐞𝐚𝐫𝐥𝐲 𝐛𝐢𝐫𝐝 𝐩𝐫𝐢𝐜𝐢𝐧𝐠 ➡ https://lnkd.in/g84STPHx Join us at the University of Maryland, Baltimore, on January 27 & 28, 2025. Meet Mark Leibman, Regulatory Affairs Intelligence Director, Oncology at AstraZeneca, and Jody Roth, Senior Vice President of Global Regulatory Affairs and Medical Writing at Immunovant. They will co-host the 𝐃𝐢𝐯𝐞𝐫𝐬𝐢𝐭𝐲 𝐢𝐧 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐓𝐫𝐚𝐢𝐥𝐬 Session on Day 1. They are bringing together top speakers from both the agency and industry for dynamic conversations and interactive panel discussions, giving attendees a unique chance to engage in questions directly with the experts. This is an intimate opportunity to learn from the best in the field and supercharge your professional growth! We can't wait to see you there! #RECON #UniversityOfMarylandBaltimore #DrugDevelopment #Pharma #ClinicalTrials #ClinicalTrialDiversity #ProjectOptimus #Biomarkers #RegulatoryStrategy #FDA #RegulatoryHarmonization #VivproCorp #MorePowerToYou

With great excitement, we announce that Dr. Aloka Chakravarty, a leading figure in our industry, will join us as a Keynote Speaker at RECON 2025! With a distinguished career spanning key roles at the US FDA and now serving as Vice President, Head of Enterprise Real-World Evidence at Pfizer, Dr. Chakravarty is an internationally renowned expert in multi-regional clinical trials, biomarker research, and safety evaluation. We can't wait to hear her valuable insights and engage in thought-provoking discussions during our panel. Don’t miss this incredible opportunity to learn from a true leader in the field! ➡ Lock in your spot with early bird pricing and register now- https://lnkd.in/g84STPHx #RECON2025 #RECON #FDAInsights #FDA #DrugRegulation #NewDrugApprovals #DrugDevelopment #Pharma #BioTech #UniversityofMaryland #Vivpro #VivproVarsity #MorePowerToYou

We are thrilled to announce that Dr. peter stein will once again deliver the Keynote Session for Day 1 at RECON 2025. Dr.Stein is the Deputy Director at the Office of New Drugs, Center for Drug Evaluation and Research (CDER), at the US FDA. With a wealth of experience and knowledge, Dr. Stein leads one of the most critical offices in drug regulation. Join us as he shares invaluable insights and perspectives on the evolving landscape of new drug approvals and regulatory strategies. ➡ Lock in your spot with early bird pricing and register now- https://lnkd.in/g84STPHx #RECON2025 #RECON #FDAInsights #FDA #DrugRegulation #NewDrugApprovals #DrugDevelopment #Pharma #BioTech #UniversityofMaryland #Vivpro #VivproVarsity #MorePowerToYou

We are live at TOPRA - The Organisation for Professionals in Regulatory Affairs Symposium! Join us at booth #1 for a demonstration of #RIA and see firsthand how we are democratizing R&D with #GenAI. Missed the conference? No worries! Let's connect, and we'd love to provide you with a personalized demo! ➡ https://vivpro.ai/contact #TOPRA #TopraSymposium #VivproCorp #MorePowerToYou

Vivpro Corp is thrilled to join TOPRA - The Organisation for Professionals in Regulatory Affairs Symposium for the first time! -It is a prime opportunity for us to connect with academia, industry leaders, and regulatory agencies. Join us at Booth 1 for a #RIA demonstration and chat with our CEO, Pravin Jadhav, about how we are revolutionizing drug development with #GenAI. Planning to attend? ➡ Drop us a comment. We'd love to connect! #TOPRA #TopraSymposium #VivproCorp #MorePowerToYou